Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Calgary
$120,000.00
Using Single-Cell Genomics to Discover Therapeutic Resistance Mechanisms in Human Colorectal Cancer
EF 2024-25
Résumé
Every year, 25,200 Canadians are diagnosed with colorectal cancer, and 9,400 die from it, making it a major cause of cancer deaths in Canada. This type of cancer becomes particularly dangerous when it spreads from the colon to other vital organs like the lungs and liver. Unfortunately, traditional treatments such as chemotherapy and radiation therapy are often ineffective against advanced cancer stages, with only about 15% of patients living longer than five years.
Immunotherapy, which enhances our own immune system's ability to fight cancer, has been a game-changer in treating skin cancers and shows potential for treating colorectal cancer as well. However, it does not work for over 80% of colorectal cancer patients. In collaboration with clinical partners at Calgary's Foothills Hospital, I gained access to primary human colorectal cancer samples. I have established several tissue cultures using these human patients' cancerous tissues and followed up with detailed genomic exploration at the single-cell level. My efforts so far have led to the discovery of different cancer stem cells that associated with varying levels of resistance to treatments like chemotherapy, radiation therapy, and immunotherapy, and these cells seem to be ultimately responsible for unfavorable clinical outcomes.
Moving forward, my next goal is to understand the specific roles these cancer cells play and the mechanisms that determine their behavior and impact, particularly their role in resisting immunotherapy. I aim to identify how these cells interact with the immune system to resist treatments. By working alongside researchers, clinicians, and colorectal cancer patients and their families, I hope to confirm my findings in real-world settings and possibly pinpoint new genes that could be targeted to enhance treatment efficacy. The results obtained from my project promise to identify new ways of treating colorectal cancer, potentially increasing patient survival.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
518095
Name
Chua Julian C
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Using Single-Cell Genomics to Discover Therapeutic Resistance Mechanisms in Human Colorectal Cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Adoptive Cell Therapy; Assay For Transposase-Accessible Chromatin Sequencing; Cd8 Positive T Cells; Colorectal Cancer; Immune Deficient Cancer Stem Cells; Immunotherapy; Immunotherapy Resistance; Microsatellite Stable; Patient Derived Organoids; Single-Cell Rna Sequencing
Abstract
Every year, 25,200 Canadians are diagnosed with colorectal cancer, and 9,400 die from it, making it a major cause of cancer deaths in Canada. This type of cancer becomes particularly dangerous when it spreads from the colon to other vital organs like the lungs and liver. Unfortunately, traditional treatments such as chemotherapy and radiation therapy are often ineffective against advanced cancer stages, with only about 15% of patients living longer than five years.
Immunotherapy, which enhances our own immune system's ability to fight cancer, has been a game-changer in treating skin cancers and shows potential for treating colorectal cancer as well. However, it does not work for over 80% of colorectal cancer patients. In collaboration with clinical partners at Calgary's Foothills Hospital, I gained access to primary human colorectal cancer samples. I have established several tissue cultures using these human patients' cancerous tissues and followed up with detailed genomic exploration at the single-cell level. My efforts so far have led to the discovery of different cancer stem cells that associated with varying levels of resistance to treatments like chemotherapy, radiation therapy, and immunotherapy, and these cells seem to be ultimately responsible for unfavorable clinical outcomes.
Moving forward, my next goal is to understand the specific roles these cancer cells play and the mechanisms that determine their behavior and impact, particularly their role in resisting immunotherapy. I aim to identify how these cells interact with the immune system to resist treatments. By working alongside researchers, clinicians, and colorectal cancer patients and their families, I hope to confirm my findings in real-world settings and possibly pinpoint new genes that could be targeted to enhance treatment efficacy. The results obtained from my project promise to identify new ways of treating colorectal cancer, potentially increasing patient survival.
Competitiondate
202411
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Chua, Julian C
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~